JNJ Trading Analysis - 10/23/2026 12:43 PM — TRU-SENTIMENT

News Headlines & Context

Recent general-knowledge headlines and context for Johnson & Johnson (JNJ) that may relate to the provided data:

• JNJ announced progress in its pharmaceutical pipeline with late-stage trial readouts expected before year-end, supporting defensive sector interest.
• The company confirmed an ex-dividend date of November 24, 2026, with a dividend rate of $5.36 (yield 2.07%), often attracting income buyers into late October.
• MedTech segment supply-chain normalization was cited in industry reports, potentially easing prior margin pressure.
• No major negative litigation surprise has dominated recent news flow, though legacy talc-related appeals remain a background risk.
• Broader healthcare rotation amid low market beta (JNJ beta 0.07) has kept the stock less correlated to index swings.

Context: The bullish options sentiment and sharp Oct 22 rally to $268.63 may reflect steady fundamental support and dividend timing rather than speculative hype, though technicals show mixed direction.

Fundamental Analysis

Based strictly on the embedded FUNDAMENTALS data for JNJ:

• Trailing P/E is 38.90 with trailing EPS of $6.68; forward P/E, PEG, and price-to-book are null (not provided).
• Dividend yield 2.07% ($5.36 rate), ex-dividend date 2026-11-24; market cap $647.37 billion; shares outstanding 2.41 billion.
• 52-week range: $184.66 low to $281.07 high; current price $268.63 sits in upper-middle of range.
• Beta 0.07 indicates very low systemic volatility; institutional ownership 50.11%.
• Historical volatility 24.06%; average volume 7.64 million vs recent daily ~5.4 million.
• Revenue growth, margins, ROE, debt/equity, and free cash flow are null (not provided) — cannot assess directly.
• Analyst consensus and target mean price are null; no recommendation key provided.

Fundamentals show a high trailing P/E (38.90) with stable dividend and极低 beta, contrasting the data's technical indecision and bullish options flow. Valuation appears rich versus typical peer P/E without growth metrics to justify it.

Current Market Position

Current price from indicators: $268.63 (2026-10-22 close). Daily history shows Oct 22 closed $268.63 after opening $260.54, high $269.67, low $259.04, volume 5,421,638 — a strong upward day.

Minute bars (Oct 21–22): Oct 21 09:30 close $257.02; Oct 22 15:55 close $267.64 with final bar volume 611,877 (spiking late). Intraday trend moved from ~$257 to ~$268, showing late-session momentum though last 5 bars declined from $268.93 to $267.64.

Technical Analysis

SMA alignment: price $268.63 > SMA 50 ($265.20) > SMA 20 ($259.42) > SMA 5 ($258.85). No golden/death cross; price recovered above all SMAs on Oct 22. RSI 61.60 shows moderate bullish momentum, not overbought. MACD (-1.63) below signal (-1.31), histogram -0.33 = bearish bias despite price rise (divergence). Bollinger: middle $259.42, upper $272.13, lower $246.71; price near upper band = expansion. 30d range high $275.23, low $245.17; price at 78.4% of range.

True Sentiment Analysis (Delta 40-60 Options)

Options flow (Delta 40-60 only): Bullish

Call Dollar Volume: $534,785.00 (66.10%) Put Dollar Volume: $274,645.00 (33.90%) Total: $809,430.00

Call contracts 556 vs put 299; sentiment bullish with pure directional conviction favoring calls. This suggests near-term upside expectations, but spread recommendation engine flagged divergence: "Options sentiment is Bullish but technicals show no clear direction." Technical MACD negative contradicts flow.

Key Price Levels (Observational Only)